Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2020-02-14 12:03 pm Purchase | 13G | MOELIS & CO MC | Capital Research Global Investors | 2,986,500 6% | 2,986,500 (New Position) | View |
2020-02-14 12:03 pm Purchase | 13G | MADRIGAL PHARMACEUTICALS INC C MDGL | Capital Research Global Investors | 1,697,119 10.9% | 32,667 (+1.96%) | View |
2020-02-14 12:03 pm Sale | 13G | CRYOLIFE INC. CRY | Capital Research Global Investors | 1,539,587 4.1% | -832,913 (-35.11%) | View |
2020-02-14 12:03 pm Sale | 13G | ALCOA UPSTREAM CORP AA | Capital Research Global Investors | 19,452,499 10.4% | -512,158 (-2.57%) | View |
2020-02-14 12:03 pm Sale | 13G | ABBOTT LABS ABT | Capital Research Global Investors | 113,689,293 6.4% | -8,239,053 (-6.76%) | View |
2020-02-14 12:03 pm Purchase | 13G | ALLAKOS INC ALLK | Capital Research Global Investors | 5,386,845 11% | 327,375 (+6.47%) | View |
2020-02-14 12:03 pm Purchase | 13G | AMGEN INC AMGN | Capital Research Global Investors | 35,337,639 5.9% | 192,664 (+0.55%) | View |
2020-02-14 12:03 pm Sale | 13G | ATI INC. ATI | Capital Research Global Investors | 6,646,030 5.2% | -2,217,950 (-25.02%) | View |
2020-02-14 12:03 pm Purchase | 13G | BIOMARIN PHARMACEUTICAL INC BMRN | Capital Research Global Investors | 22,004,065 12.2% | 3,699,902 (+20.21%) | View |
2020-02-14 12:03 pm Purchase | 13G | DINE BRANDS GLOBAL, INC. DIN | Capital Research Global Investors | 2,039,724 12.1% | 115,779 (+6.02%) | View |
2020-02-14 12:03 pm Sale | 13G | AMERICAN INTL GROUP INC AIG | Capital Research Global Investors | 36,497,611 4.2% | -10,740,345 (-22.74%) | View |
2020-02-14 12:03 pm Purchase | 13G | ALLOGENE THERAPEUTICS INC ALLO | Capital Research Global Investors | 6,542,678 5.3% | 6,542,678 (New Position) | View |
2020-02-14 12:03 pm Purchase | 13G | BLUEBIRD BIO INC BLUE | Capital Research Global Investors | 6,779,133 12.2% | 79,702 (+1.19%) | View |
2020-02-14 12:03 pm Sale | 13G | DISCOVERY INC SER A DISCA | Capital Research Global Investors | 0 0% | -11,743,943 (Position Closed) | View |
2020-02-14 12:03 pm Purchase | 13G | FRONTIER HEALTH CORP SHS NFH | Capital Research Global Investors | 11,193,186 8.5% | 11,193,186 (New Position) | View |
2020-02-14 12:03 pm Sale | 13G | EHI CAR SVCS LTD SPON ADS REPS EHIC | Capital Research Global Investors | 0 0% | -3,777,400 (Position Closed) | View |
2020-02-14 12:03 pm Purchase | 13G | ENDURANCE INTL GROUP HLDGS INC EIGI | Capital Research Global Investors | 11,304,955 7.7% | 1,433,229 (+14.52%) | View |
2020-02-14 12:03 pm Sale | 13G | ESSENT GROUP LTD COM SHS ESNT | Capital Research Global Investors | 9,026,383 9.1% | -541,438 (-5.66%) | View |
2020-02-14 12:03 pm Purchase | 13G | DIAMONDBACK ENERGY INC FANG | Capital Research Global Investors | 19,577,175 12.2% | 1,929,183 (+10.93%) | View |
2020-02-14 12:03 pm Sale | 13G | FREEPORT-MCMORAN INC C FCX | Capital Research Global Investors | 90,060,943 6.2% | -69,330,439 (-43.50%) | View |